Drugs Made In America Acquisition Restates Merger With Power Analytics at $2.85 Billion Value

Drugs Made In America Acquisition entered into an Amended and Restated Definitive Merger Agreement with Power Analytics Global on Sep 8, 2026 to complete their business combination. The deal fixes a $2.85 billion equity valuation for PAGC (inclusive of APQC and UltraSolar IP) and provides stock con…